These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17985200)

  • 21. Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer.
    Williams CS; Leek RD; Robson AM; Banerji S; Prevo R; Harris AL; Jackson DG
    J Pathol; 2003 Jun; 200(2):195-206. PubMed ID: 12754740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors.
    Mattila MM; Ruohola JK; Karpanen T; Jackson DG; Alitalo K; Härkönen PL
    Int J Cancer; 2002 Apr; 98(6):946-51. PubMed ID: 11948478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insights into the mechanisms of lymph node metastasis.
    Nathanson SD
    Cancer; 2003 Jul; 98(2):413-23. PubMed ID: 12872364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
    Chen YN; Gu Y
    Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis.
    Skobe M; Hawighorst T; Jackson DG; Prevo R; Janes L; Velasco P; Riccardi L; Alitalo K; Claffey K; Detmar M
    Nat Med; 2001 Feb; 7(2):192-8. PubMed ID: 11175850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up.
    Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
    Clin Cancer Res; 2003 Feb; 9(2):716-21. PubMed ID: 12576440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphatic vessel activation in cancer.
    Cassella M; Skobe M
    Ann N Y Acad Sci; 2002 Dec; 979():120-30. PubMed ID: 12543722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.
    Bolenz C; Fernández MI; Tilki D; Herrmann E; Heinzelbecker J; Ergün S; Ströbel P; Reich O; Michel MS; Trojan L
    BJU Int; 2009 Sep; 104(5):592-7. PubMed ID: 19594740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
    Hou Q; Chen S; An Q; Li B; Fu Y; Luo Y
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphangiogenesis and lymph node metastasis in breast cancer.
    Cunnick GH; Jiang WG; Douglas-Jones T; Watkins G; Gomez KF; Morgan MJ; Subramanian A; Mokbel K; Mansel RE
    Mol Cancer; 2008 Mar; 7():23. PubMed ID: 18325094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3-O-Acetyloleanolic acid inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis in an oral cancer sentinel lymph node animal model.
    Hwang-Bo J; Bae MG; Park JH; Chung IS
    BMC Cancer; 2018 Jul; 18(1):714. PubMed ID: 29976150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
    Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
    BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis.
    Martínez-Iglesias O; Olmeda D; Alonso-Merino E; Gómez-Rey S; González-López AM; Luengo E; Soengas MS; Palacios J; Regadera J; Aranda A
    Oncotarget; 2016 Nov; 7(48):78971-78984. PubMed ID: 27806339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphatic vessels assessment in feline mammary tumours.
    Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
    BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor Invasiveness, Not Lymphangiogenesis, Is Correlated with Lymph Node Metastasis and Unfavorable Prognosis in Young Breast Cancer Patients (≤35 Years).
    Zhang ZQ; Han YZ; Nian Q; Chen G; Cui SQ; Wang XY
    PLoS One; 2015; 10(12):e0144376. PubMed ID: 26656588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes.
    Shriver CD; Hueman MT; Ellsworth RE
    J Exp Clin Cancer Res; 2014 Dec; 33(1):116. PubMed ID: 25551369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
    Frewer NC; Ye L; Sun PH; Owen S; Ji K; Frewer KA; Hargest R; Jiang WG
    Int J Mol Med; 2013 May; 31(5):1097-104. PubMed ID: 23546515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.